(Q38165233)

30 August 2017

title

How are eczema 'flares' defined? A systematic review and recommendation for future studies (English)

1 reference

30 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kim Thomas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

J Schmitt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

H C Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

S Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

1 March 2014

1 reference

British Journal of Dermatology

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

548-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

8 June 2020

cites work

1 reference

Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies

21 January 2018

1 reference

Patients' and clinicians' research priorities

21 January 2018

1 reference

Avoidable waste in the production and reporting of research evidence

21 January 2018

1 reference

Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting

21 January 2018

1 reference

Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process

21 January 2018

1 reference

Asthma outcomes: exacerbations

21 January 2018

1 reference

Asthma outcomes: composite scores of asthma control

21 January 2018

1 reference

What is meant by a "flare" in atopic dermatitis? A systematic review and proposal

21 January 2018

1 reference

What causes flares of eczema in children?

21 January 2018

1 reference

Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease

21 January 2018

1 reference

Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial

21 January 2018

1 reference

Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle

21 January 2018

1 reference

Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?

21 January 2018

1 reference

Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis.

21 January 2018

1 reference

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

21 January 2018

1 reference

Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial

21 January 2018

1 reference

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study

21 January 2018

1 reference

Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial.

21 January 2018

1 reference

Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

21 January 2018

1 reference

MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study

21 January 2018

1 reference

Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis

21 January 2018

1 reference

Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies

21 January 2018

1 reference

Percutaneous absorption of pimecrolimus is not increased in patients with moderate to severe atopic dermatitis when pimecrolimus cream 1% is applied under occlusion

21 January 2018

1 reference

Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.

21 January 2018

1 reference

Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis

21 January 2018

1 reference

Sugar is not an aggravating factor in atopic dermatitis

21 January 2018

1 reference

Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study

21 January 2018

1 reference

Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis

21 January 2018

1 reference

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

21 January 2018

1 reference

Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.

21 January 2018

1 reference

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

21 January 2018

1 reference

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

21 January 2018

1 reference

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

21 January 2018

1 reference

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children

21 January 2018

1 reference

Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis

21 January 2018

1 reference

Patient non-compliance with paper diaries

21 January 2018

1 reference

Developing core outcome sets for clinical trials: issues to consider

21 January 2018

1 reference

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.

21 January 2018

1 reference

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.

21 January 2018

1 reference

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

Patient Perspective: Choosing or Developing Instruments

21 January 2018

1 reference

Developing a Construct to Evaluate Flares in Rheumatoid Arthritis: A Conceptual Report of the OMERACT RA Flare Definition Working Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJD.12747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json

release_2xflsuvc45dxlaubzimucycx2i

8 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2xflsuvc45dxlaubzimucycx2i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24266741%20AND%20SRC:MED&resulttype=core&format=json